Intravitreal bevacizumab versus combined intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration: six-month results of a randomized clinical trial (Q84069733)
Jump to navigation
Jump to search
scientific article published on 01 October 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intravitreal bevacizumab versus combined intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration: six-month results of a randomized clinical trial |
scientific article published on 01 October 2011 |
Statements
Intravitreal bevacizumab versus combined intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration: six-month results of a randomized clinical trial (English)
Hamid Ahmadieh
Ramin Taei
Mohammad Riazi-Esfahani
Niloufar Piri
Mansour Homayouni
1 October 2011